Myriad acts in High Court's first consideration of genetic material patents
Client(s) Myriad Genetics, Inc.
Jones Day acted for Myriad Genetics, Inc. in a landmark Australian case before the High Court of Australia. The case represents the first time an Australian court considered the patentability of genetic material, a case in which Jones Day also acted before the U.S. Supreme Court.
D’Arcy v. Myriad Genetics Inc  HCA 35